You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 103 No. 8, August 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  EXPEDITED PUBLICATION
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Risk of Cerebrovascular and Cardiovascular Disease in Patients With Anterior Ischemic Optic Neuropathy

David R. Guyer, MD; Neil R. Miller, MD; Cheryl L. Auer, MS; Stuart L. Fine, MD

Arch Ophthalmol. 1985;103(8):1136-1142.


Abstract

• Of 217 patients in whom anterior ischemic optic neuropathy (AION) was diagnosed during the period from 1975 to 1985, verifiable medical information was obtained for 212 (98%). Over a median follow-up period of three years, no group of patients had an increased mortality rate over that of age-, sex-, and race-matched controls; however, patients with "idiopathic" AION and patients with systemic hypertension who developed nonarteritic AION had a statistically significant increased risk of experiencing cerebrovascular events and myocardial infarctions compared with appropriately matched control groups. In view of the findings of our study, we suggest that patients with idiopathic AION and hypertensive patients who develop nonarteritic AION undergo a complete physical examination, cardiac evaluation, tests of carotid artery patency, and careful medical follow-up to attempt to prevent subsequent cerebrovascular or cardiovascular events.



Author Affiliations

From the Neuro-Ophthalmology Unit and the Retinal Vascular Center, The Wilmer Eye Institute, The Johns Hopkins Medical Institutions, Baltimore.


Footnotes

Accepted for publication May 31, 1985.

Reprint requests to The Wilmer Eye Institute, The Johns Hopkins Medical Institutions, 600 N Wolfe St, Baltimore, MD 21205 (Dr Miller).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Association of Retinal Vessel Caliber to Optic Disc and Cup Diameters
Lee et al.
IOVS 2007;48:63-67.
ABSTRACT | FULL TEXT  

Preventing Visual Loss From Chronic Eye Disease in Primary Care: Scientific Review
Rowe et al.
JAMA 2004;291:1487-1495.
ABSTRACT | FULL TEXT  

Nonarteritic Anterior Ischemic Optic Neuropathy: Enigma Variations
Lessell
Arch Ophthalmol 1999;117:386-388.
FULL TEXT  

Nonarteritic Anterior Ischemic Optic Neuropathy: A Case-Control Study of Potential Risk Factors
Jacobson et al.
Arch Ophthalmol 1997;115:1403-1407.
ABSTRACT  

Characteristics of Patients With Nonarteritic Anterior Ischemic Optic Neuropathy Eligible for the Ischemic Optic Neuropathy Decompression Trial
Ischemic Optic Neuropathy Decompression Trial Stud
Arch Ophthalmol 1996;114:1366-1374.
ABSTRACT  

24-Hour Blood Pressure Monitoring in Patients With Anterior Ischemic Optic Neuropathy
Landau et al.
Arch Ophthalmol 1996;114:570-575.
ABSTRACT  

The Role of Carotid Endarterectomy in Ischemic Optic Neuropathy
Ellenberger
Arch Ophthalmol 1985;103:1633-1633.
ABSTRACT  

The Role of Carotid Endarterectomy in Ischemic Optic Neuropathy
Lavin
Arch Ophthalmol 1985;103:1633-1634.
ABSTRACT  

Acute Ischemic Optic Neuropathy
Goodwin
JAMA 1985;254:951-952.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.